This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Steinbach, D. Articles by Efferth, T. Search for Related Content PubMed PubMed Citation Articles by Steinbach, D. Articles by Efferth, T.

ABCA3 as a Possible Cause of Drug Resistance in Childhood Acute Myeloid Leukemia

Authors' Affiliations: ¹ Children's Hospital, University of Jena, Jena, Germany; ² Department of Biology, University of Namur; ³ Eppendorf Array Technologies, Namur, Belgium; ⁴ Helios Children's Hospital, Erfurt, Germany; and ⁵ Center for Molecular Biology, University of Heidelberg, Heidelberg, Germany

Requests for reprints: Daniel Steinbach, Klinikum der FSU Jena, Klinik für Kinder- und Jugendmedizin, Postfach, 07740 Jena, Germany. Phone: 49-3641-938270; Fax: 49-3641-938306; E-mail: Daniel{at}Steinba.ch.

Background: A major issue in the treatment of acute myeloid leukemia (AML) is resistance to chemotherapeutic drugs. Multidrug resistance can be caused by ATP-binding cassette (ABC) transporters that function as drug efflux pumps. The majority of these proteins have not yet been examined in malignant diseases.

Experimental Design: A newly developed microarray for the simultaneous quantification of 38 ABC transporter genes and Taqman real-time PCR was used to analyze the expression of ABC transporters in pediatric AML and healthy bone marrow. Small interfering RNA was used to verify the role of ABCA3 in drug resistance.

Results: Using the microarray, we identified four new ABC transporters, which were overexpressed in many AML samples compared with healthy bone marrow: ABCA2, ABCA3, ABCB2, and ABCC10. The overexpression of these four genes was verified by real-time PCR in 42 samples from children with AML and 18 samples of healthy bone marrow. The median expression of ABCA3 was three times higher in 21 patients who had failed to achieve remission after the first course of chemotherapy than in a well-matched group of 21 patients who had achieved remission at this stage (P = 0.023). Incubation of cell lines with a number of different cytostatic drugs induced an up-regulation of ABCA3. Down-regulation of ABCA3 by small interfering RNA sensitized cells to doxorubicin.

Conclusion: Our results show that ABCA2, ABCA3, ABCB2, and ABCC10 are overexpressed in childhood AML compared with healthy bone marrow. ABCA3 is the most likely transporter to cause drug resistance.